MEKK1 deficiency in mice subjected to pressure overload abolished JNK activation but did not prevent cardiac hypertrophy, instead leading to significantly increased cardiac myocyte apoptosis and progression to heart failure.
MEKK1 protects against heart failure, apoptosis, and inflammation following pressure overload, but is not required for pressure overload-induced cardiac hypertrophy.
Absolute Event Rate: 1.5% vs 0.44%
p-value: p=0.02
Mitogen-activated protein kinase kinase kinase (MEKK1) mediates activation of c-Jun NH2-terminal kinase (JNK). Although previous studies using cultured cardiac myocytes have suggested that the MEKK1-JNK pathway plays a key role in hypertrophy and apoptosis, its effects in cardiac hypertrophy and apoptosis are not fully understood in adult animals in vivo. We examined the role of the MEKK1-JNK pathway in pressure-overloaded hearts by using mice deficient in MEKK1. We found that transverse aortic banding significantly increased JNK activity in Mekk1+/+ but not Mekk1–/– mice, indicating that MEKK1 mediates JNK activation by pressure overload. Nevertheless, pressure overload caused significant levels of cardiac hypertrophy and expression of atrial natriuretic factor in Mekk1–/– animals, which showed higher mortality and lung/body weight ratio than were seen in controls. Fourteen days after banding, Mekk1–/– hearts were dilated, and their left ventricular ejection fraction was low. Pressure overload caused elevated levels of apoptosis and inflammatory lesions in these mice and produced a smaller increase in TGF-β and TNF-α expression than occurred in wild-type controls. Thus, MEKK1 appears to be required for pressure overload–induced JNK activation and cytokine upregulation but to be dispensable for pressure overload–induced cardiac hypertrophy. MEKK1 also prevents apoptosis and inflammation, thereby protecting against heart failure and sudden death following cardiac pressure overload.
Sadoshima et al. (Mon,) conducted a other in Cardiac hypertrophy and heart failure. MEKK1 deficiency vs. Wild-type (MEKK1+/+) was evaluated on TUNEL-positive myocytes in LV myocardium at 7 days (myocytes/mm2) (p=0.02). MEKK1 deficiency in mice subjected to pressure overload abolished JNK activation but did not prevent cardiac hypertrophy, instead leading to significantly increased cardiac myocyte apoptosis and progression to heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: